Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

18.41 +1.09 (+6.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Earnings Scheduled For February 18, 2025 ↗

February 18, 2025

Via Benzinga

5 Analysts Assess NeoGenomics: What You Need To Know ↗

January 15, 2025

Via Benzinga

Evaluating NeoGenomics: Insights From 4 Financial Analysts ↗

December 10, 2024

Via Benzinga

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

February 17, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review ↗

January 17, 2025

Many stocks flashed buy signals as the major indexes rose to or above key levels.

Via Investor's Business Daily

Topics Economy

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance ↗

January 15, 2025

The company expects sales to grow 12% to 13% annually in the long term.

Via Investor's Business Daily

NeoGenomics Shares Are Falling Today: What's Going On? ↗

January 10, 2025

Shares of NeoGenomics, Inc. (NASDAQ: NEO) are, after the company announced that CEO Chris Smith will retire effective April 1 2025.

Via Benzinga

Expert Ratings For NeoGenomics ↗

September 24, 2024

Via Benzinga

NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024 ↗

July 29, 2024

NEO stock results show that NeoGenomics beat on revenue for the second quarter of 2024.

Via InvestorPlace

NeoGenomics Earnings Analysis: Q1 Recap ↗

May 10, 2024

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!

Via Benzinga

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

Where NeoGenomics Stands With Analysts ↗

April 30, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About NeoGenomics ↗

March 18, 2024

Via Benzinga

Evaluating NeoGenomics: Insights From 4 Financial Analysts ↗

February 21, 2024

Via Benzinga

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday ↗

July 30, 2024

Via Benzinga

NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024 ↗

April 30, 2024

NEO stock results show that NeoGenomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 15, 2024 ↗

March 15, 2024

Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.

Via Benzinga

Recap: NeoGenomics Q4 Earnings ↗

February 20, 2024

Via Benzinga

Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know ↗

February 22, 2024

Via Benzinga

NeoGenomics Stock Surged But Technicals Point To A Pullback ↗

February 22, 2024

NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than...

Via Talk Markets

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today? ↗

February 21, 2024

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an...

Via Benzinga

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2024

Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 21, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.